Gene · 1642
Papers3,503
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,503
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA-Encoded Library (DEL) Selection Identifies a Distinct DDB1 Ligand Binding Site. | ACS Med Chem Lett | 2026 | 41982729 | PubTator, text mining | PubMed |
| Targeting the RNA-binding motif protein 15 suppresses prostate cancer progression and hormone therapy resistance by promoting androgen receptor degradation. | Mol Biomed | 2026 | 41949706 | PubTator, text mining | PubMed |
| An interactome-based framework for DDB1- and CUL4-associated factor prioritization in targeted protein degradation. | Mol Cell | 2026 | 41932313 | PubTator, text mining | PubMed |
| Uncovering BAP1 deubiquitination landscape enhances mechanism elucidation and therapeutic precision for BAP1-deficient pancancers. | Sci Transl Med | 2026 | 41920966 | PubTator, text mining | PubMed |
| MVGAE: A Multi-View Graph Auto-Encoder Model for Drug Prediction of Non-Small Cell Lung Cancer Based on Synthetic Lethality. | Curr Issues Mol Biol | 2026 | 41899421 | PubTator, text mining | PubMed |
| Stability of c-Myc Protein in Early S Phase Is Regulated by the Interaction with PCNA. | Int J Mol Sci | 2026 | 41898606 | PubTator, text mining | PubMed |
| USP10 deubiquitinase: Physiological function, diseases and therapeutic target (Review). | Int J Mol Med | 2026 | 41891958 | PubTator, text mining | PubMed |
| DR5/WDR12 balances p65 stability promoting sunitinib resistance in renal cell carcinoma. | Cell Death Differ | 2026 | 41872532 | PubTator, text mining | PubMed |
| Innate immune recognition and evasion strategies of hepatitis B virus: from DNA to RNA and viral proteins. | Front Immunol | 2026 | 41869349 | PubTator, text mining | PubMed |
| CAND1 and CAND2 drive CUL4 substrate receptor exchange with largely comparable biochemical efficiency, unlike their relative effects on CUL1. | Structure | 2026 | 41864201 | PubTator, text mining | PubMed |
| The JMJD family histone demethylases: structure, mechanism of action, diseases and therapeutic targets. | Mol Biomed | 2026 | 41857315 | PubTator, text mining | PubMed |
| Prospects and advances of PROTAC in the treatment of hematologic malignancies. | Exp Hematol Oncol | 2026 | 41845415 | PubTator, text mining | PubMed |
| Epigenomic and Metabolic Interplay in the Development of Metastatic Brain Tumors. | Oncol Res | 2026 | 41799524 | PubTator, text mining | PubMed |
| Pro-tumourigenic effects of DCAF13 on the progression of colorectal cancer. | Oncol Lett | 2026 | 41797888 | PubTator, text mining | PubMed |
| Native chromatome profiling reveals hundreds of metabolic enzymes in the nucleus across tissues. | Nat Commun | 2026 | 41792114 | PubTator, text mining | PubMed |
| Scalable insect cell expression and purification screening applied to CRL4-DCAF substrate receptors. | Protein Expr Purif | 2026 | 41785791 | PubTator, text mining | PubMed |
| Detection of germline variants in human population chronically exposed to high level natural background radiation in Kerala coast. | Genes Environ | 2026 | 41761368 | PubTator, text mining | PubMed |
| PROTAC-based protein degradation: a window of opportunity for melanoma therapy. | J Biomed Sci | 2026 | 41761284 | PubTator, text mining | PubMed |
| Takotsubo Syndrome: The First Non-Acute Proteomic Analysis by Remote Dried Blood Microsampling. | J Cardiovasc Transl Res | 2026 | 41760974 | PubTator, text mining | PubMed |
| Molecular mechanisms and therapies for tumor inhibition through the arginine metabolism pathway. | Front Oncol | 2026 | 41756322 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1642/papers?page=2